Navigation Links
Molecular Devices Introduces SpectraMax DuoLuc Reporter Assay Kit
Date:4/18/2017

Molecular Devices announced today an addition to its assay kits portfolio with the launch of the new SpectraMax® DuoLuc™ Reporter Assay Kit enabling highly sensitive quantitation of both firefly and Renilla luciferases in mammalian cells.

Reporter gene assays are an important tool for researchers to monitor cellular events associated with gene expression, gene regulation, and signal transduction. Firefly luciferase, one of the most commonly used reporters, produces light by catalyzing a bioluminescence reaction that oxidizes D-luciferin in the presence of oxygen and ATP. Renilla luciferase catalyzes coelenterazine oxidation to produce light. Due to the difference in substrate requirements, it is possible to measure the activity of both luciferases in a single sample through sequential addition of the substrates. The result is a convenient assay with two readouts that can be normalized to each other to provide more complete information about a cellular pathway or event.

The SpectraMax DuoLuc Reporter Assay Kit detects firefly and Renilla luciferase expression in as few as ten cells per well, improves accuracy of results by normalizing reporter expression to a control, and speeds time to results with a preconfigured SoftMax® Pro Software protocol optimized for luminescence microplate readers with injectors.

Scott Greenstone, Director of Reagents at Molecular Devices, commented: “We are very excited to finally give customers a choice when it comes to dual luciferase assays. Not only do we support the complete solution for readers, software and assays, we offer better pricing too.”

About Molecular Devices, LLC

Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.

For more information, visit:
http://www.moleculardevices.com/duoluc

Read the full story at http://www.prweb.com/releases/2017/04/prweb14241183.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Molecular or Immunoassay? Which Technology Will Win the Race for the Point of Care Diagnostics Market?
2. 2017 Foresight Fellows Announced in Molecular Machines, Space, Longevity, Artificial Intelligence
3. Molecular Assemblies Appoints Floyd E. Romesberg from The Scripps Research Institute to Scientific Advisory Board
4. Caprion Biosciences wird Kurzlehrgang und Poster bei Molecular Medicine Tri-Conference in San Francisco präsentieren
5. Global Biomarkers Technologies, Markets and Companies Report 2017-2025: Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics - Research and Markets
6. Global Molecular Diagnostics Analysis Report 2010-2016: Deal Trends, Key Players, Top Deal Values & Deals Financials - Research and Markets
7. Benchling Announces First Of Its Kind Molecular Biology 2.0 Software Enabling Scientists To Run Thousands Of Experiments At Once
8. Global Molecular Diagnostics Research Report 2017: Focus on Technologies, Applications, Regulations, Markets and Companies to 2025 - Research and Markets
9. Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business
10. Molecular Diagnostic Market for Group A Streptococcus Nucleic Acid Test Products - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023
11. Molecular Assemblies Raises $2.3 Million in Seed Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2019)... ... March 14, 2019 , ... Xybion ... research organizations. It is a low code, GDPR/21 CFR Part 11-compliant digital ... technology-driven automated data capture and seamless data and information management. , ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many attributes that ... how to use the information they have from the protocol and clinical trial knowledge, ... is properly designed and set up to ensure flawless execution. As clinical trial success ...
(Date:3/9/2019)... SEATTLE (PRWEB) , ... March ... ... source for unbiased college rankings and higher education planning, announced the release ... identifies the top programs in the nation based on curriculum quality, program ...
(Date:3/4/2019)... ... ... of current hot topics through free webinars presented by leading experts in pharma, biotech, medical ... today to save your place! Participate in the discussion and stay relevant in your field! ... , March 20 – Implementing BYOD Across Phase II and III Clinical Trials ...
Breaking Biology Technology:
(Date:3/9/2019)... ... March 08, 2019 , ... Ace ... product, Well-Mints™ resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ ... naturally flavored hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology ...
(Date:3/1/2019)... (PRWEB) , ... February 28, 2019 , ... Teresa Krabbe, ... der Isar of the Technical University Munich, has been awarded an xCELLigence Research Grant ... an improved oncolytic virus platform. , Oncolytic viruses represent an exciting new ...
(Date:2/22/2019)... ... 2019 , ... RoosterBio, Inc, a privately held regenerative medicine ... Frederick, MD after a year of rapid growth. , “Hundreds of researchers and ... products to streamline their product development efforts in the regenerative medicine field, resulting ...
Breaking Biology News(10 mins):